“5th International Conference on Cancer Therapy” to be held at Toronto, Canada on August 26-27, 2019 on the theme of - Securing the future of innovation in cancer treatment. All the members from the world are invited on the Cancer Therapy Congress which gathers all the humans to share their know-how and have a discussion on the contemporary trouble on most cancers and improvement of most cancers therapies. This meeting in the fields related to cancer biology, targeted cancer therapies, and natural methods for cancer treatment, cancer bioinformatics, cancer pharmacology, and precision medicine etc.
The scientific program includes keynote & plenary talks, video presentations, poster presentations, and e-posters. Furthermore, oral communications of post doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in cancer therapy.
Session 1: Oncology Nursing
The goal of such therapy is not to cure but to improve the quality of life for both the person and their family. Evidence as of 2016 supports improvement in the quality of life. It focuses on providing people with relief from the symptoms, pain, physical stress, and mental stress of the terminal diagnosis in life-limiting diseases like cancer. Medications and treatments are found to have a palliative effect if they relieve symptoms without having a therapeutic effect on the underlying disease or cause. Given in addition to cancer treatment, when a patient reaches a point where the cure is not warranted, palliative care becomes the sole focus of care. The respective session of the cancer therapy conference will deal with issues like the difference between hospice care and palliative care, oncology nursing, pain management, psychosocial and emotional care on a spiritual level.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 2: Surgery
Surgical removal of cancerous cells from the body is one of the most widely used procedures for treating cancer. There are several types of surgeries which might be open or minimal invasive. Surgery is used for solid tumors unlike leukemia or any metastatic form of cancer. Cryosurgery, lasers, hyperthermia, and photodynamic therapy are a few forms that do not require any cuts and scalpels, but forms, like require cutting or debulking a tumor, sometimes with the removal of nearby lymph nodes, are the minimally invasive ones. The respective session of the cancer therapy conference shall deal with types of surgeries, their effects, and risks on a patient suffering from cancer.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 3: Chemotherapy
One of the major categories of cancer treatment methodologies, chemotherapy is the use of anticancer drugs or chemotherapeutic agents that inhibit mitosis of the cancerous cells. The intracellular poisons are infused into the body via various methods. The following session of the cancer therapy conference shall involve how to enhance the methods of the chemo regime such that the side-effects can be minimized.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 4: Hormonal Therapy
This strategy is generally used along with other treatments if the hormones interfere with cancer. Also known as endocrine therapy, its administration methods can be oral vaccination or surgical depending on the type of cancer. This session of the oncology conference will be about how organ removal or hormonal blockage affects people and advancements in the scientific field about reducing its side effects.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 5: Suicide Gene Therapy
A therapeutic strategy in which apoptosis-inducing transgenes are introduced into the cancerous cells, i.e. Cell suicide is promoted into the cells that turn cancerous. Current cancer treatments create profound iatrogenic consequences. In this cancer therapy conference, the point to be discussed is the adverse effects of the treatments that still remain, as the serious problems that practicing physicians have to cope with in clinical practice. Although non-specific cytotoxic agents constitute an effective treatment modality against cancer cells, they also tend to kill normal, quickly dividing cells. Suicide gene therapy is a new milestone in the medical world of cancer treatment that seems to have a promising future.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 6: Radiation Therapy
Radiotherapy uses high doses of radiation to shrink tumors and kill/ reduce the growth of cancer cells but damaging their dna. The types of radiation therapy are various and it is capable of tackling metastatic cancers as well. This specific session of the oncology conference shall deal with the different methods of radiotherapy; which procedure is suitable for which type of cancer, radiopharmaceuticals, and many other such aspects.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 7: Molecular Targeted Therapy
A modernized version of pharmacotherapy that blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, unlike conventional chemotherapy that interferes with all rapidly dividing cells. Molecular targeted therapy is the expected to be a more effective method therapeutically and less harmful to the normal cells in the body. This particular session of the cancer treatment conference shall emphasize the targeted therapies for various types of cancers and how its effectiveness is greater compared to the rest of the conventional treatments.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 8: Immunotherapy
A biological therapy that enhances the immune system of the body to fight cancer. Monoclonal antibodies, cytokines, adoptive cell transfer, treatment vaccines, bacillus calmette-guérin or bcg are few of the major soldiers for this purpose. Methods of immunotherapy, its effects, side effects, and advancements shall be the broader discussion area for this session of this cancer therapy conference.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 9: Stem Cell Transplant
Transplantation of stem cells does not literally act “against” cancer; instead, they help recover the ability to produce stem cells after treatment with very high doses of radiation therapy, chemotherapy, or both. HCT (Haematopoietic Cell Transplantation) is considered to be a lifesaving procedure in recent times. Thus, how to improvise the method for the betterment of the patients suffering from this lethal disease is a major concern and is to be a hot topic at the oncology conference.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 10: Regenerative Medicine
Regenerative medicines are a branch of translational research that includes the ability to grow tissues and organs in the laboratory and implanting them when the body cannot heal itself to establish normal functioning of the body. The advancements in the field are vast as extracellular matrix materials are now commercially available and are used in reconstructive surgery, treating chronic wounds as well as some orthopedic surgeries; as the reports of January 2017 clinical studies, it was underway to use them in heart surgery to repair damaged heart tissue. This session at the Cancer Therapy 2018 conference shall be about the future prospects and vital improvisations that can be brought about for this therapeutic process.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 11: Gastric Cancer and Canada
Incidence is the total number of new cases of cancer. Mortality is the number of deaths due to cancer. To provide the most current cancer statistics, researchers use the most up-to-date data available and statistical methods to estimate the number of new cancer cases and deaths for the current year.an estimated 206,200 new cases of cancer and 80,800 deaths from cancer occurred in Canada in 2018(the number of estimated new cases does not include non-melanoma skin cancer cases). Cancer is the leading cause of death in Canada and is responsible for 30% of all deaths.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Session 12: Big Data Analytics
The Cancer research communities now believe that a cure is likely to emerge not only from pure biomedical research but from the intersection of cancer biology, mathematics, machine learning, and data analytics. So it might not be surprising in today’s date to find a data scientist leading a team of researchers, scientists and developers to find the drugs to effectively treat – and ultimately defeat – cancer. Big data analytics in cancer therapy shall set a milestone in this cancer therapy conference.
Cancer Conference | Cancer Therapy Conference | Cancer Therapy Congress | Cancer Science Conference | Oncology Conference | Oncology Nursing | Cancer Science Workshop
Cancer happens to be a leading worldwide problem, with 14 million recorded new cases every year. In the USA, for example, over 0.5 million people die from cancer every year, making cancer the 2nd cause of death.Important is the fact that the cancer prevalence has been increasing mostly due to the increased lifespan of people. While recent changes in lifestyle have an impact on the spread of cancer, about two-thirds of the increase in the rate of cancer is due to longevity. More than three-quarters of all people diagnosed with cancer in the UK are over the age of 60.3
Adding to the increasing cancer prevalence, there are several reasons that currently lead to an increase in the cancer therapy market. These include the availability and high development cost of better immunotherapy agents, the non-curable and lethal nature of most of the cancer forms, the reduced competition among agents as the use of an agent does not preclude from the concurrent/subsequent use of another one, that cheaper generics are often not considered as available alternatives to newer more costly agents but they are replaced by them, the earlier diagnoses and increased chronic management, the lack of magnitude threshold of drug benefit and increased insurance premiums due to unpredictable disease status. Between the years 2007 and 2013 for instance, the global cancer therapy market more than doubled, the global cancer therapy market increased from $40.0 billion in 2007 to an estimated $47.3 billion by the end of 2008 and $110.6 billion in 2013 at a compound annual growth rate of 18.5%.
This is a high annual growth rate of over 18%. Looking at the targeted therapy separately, which constitutes 45% of the cancer therapy market, this about tripled in within the same duration, increasing from combined market cost value of about $22 billion to almost 70 billion.
The total worldwide cancer drug market approached $14.8 billion in 2000. Growing at an average annual rate (AAGR) of 12.5%, this market exceeded $26.7 billion in 2005. Established product lines currently constitute of nearly 90% of the global market, but will grow at only a rate of 6.6% AAGR through the period. Innovative therapies, climbing at an AAGR of 40.2%, reached $8.6 billion in 2005, representing 32% of the total market. Cancer therapy has the largest market with around $11.0 billion in sales in 2007. It increased to $12.0 billion in 2008 and $26.5 billion in 2013, by a CAGR of 16.4%.
Target therapy dominated in 2007 with a 45% share of the total cancer therapy market. This increased to 48% by 2008 and 62.5% in 2013.
There are ethical issues surrounding the comparative research on newer therapies for a dangerous disease like cancer, particularly the prospective research, which generally stems from the fact that exposing study participants to increased risk with experimental therapies may not actually be counterbalanced by clinical benefit. In comparative research, participants may, for example, be harmed by receiving a placebo instead of active treatment or, more commonly, participants stand the chance of receiving an experimental cancer therapy that will eventually turn out to be inferior to the best usual therapy available to patients. This is ethically problematic, given the recognized ethical principle that patients should receive the best-proven standard of care whenever feasible.
Associations around the Globe:
Consultant in Psychology & Sociology
UAE
University of Hull
UK
K S Hegde Medical College
India